Get Your Personalized Supplement StackSupplement Stack Quiz

HN001

Also known as: Lactobacillus rhamnosus HN001, Probiotic strain HN001, Lacticaseibacillus rhamnosus HN001

Overview

Lacticaseibacillus rhamnosus HN001, formerly known as Lactobacillus rhamnosus HN001, is a well-researched probiotic bacterial strain naturally found in the human gut and fermented foods. It is primarily utilized as a dietary supplement to support gut health, immune function, and, notably, mental well-being through its influence on the gut-brain axis. This strain is characterized by its robust ability to survive the harsh conditions of the gastrointestinal tract and effectively modulate the host's microbiota and immune responses. Research on HN001 is moderately mature, with several randomized controlled trials (RCTs) and meta-analyses evaluating its effects, particularly in the context of pregnancy and mental health. The evidence quality is generally good, with multiple well-designed studies supporting its benefits, especially concerning the reduction of postpartum depression and anxiety.

Benefits

Lacticaseibacillus rhamnosus HN001 offers several evidence-based benefits, with the strongest evidence supporting its role in mental health. A large double-blind RCT demonstrated that supplementation with HN001 during pregnancy and postpartum significantly reduced depression and anxiety scores in mothers, showing clinically meaningful reductions in anxiety prevalence. This benefit is particularly robust for pregnant and postpartum women. Emerging evidence suggests HN001 may also reduce stress and improve psychological well-being in other populations, such as university students facing examination-related stress. Furthermore, meta-analyses indicate a potential 33% reduction in gestational diabetes mellitus (GDM) incidence with probiotic supplementation, including strains like HN001, though strain-specific data for GDM are less clear. Secondary benefits, such as potential improvements in atopic eczema and neonatal outcomes in infants of mothers supplemented with probiotics, have been suggested, but the evidence for these effects is less robust. The mood-related benefits have been observed to manifest during pregnancy and persist for up to six months postpartum.

How it works

Lacticaseibacillus rhamnosus HN001 primarily exerts its beneficial effects by modulating the microbiome-gut-brain axis. This involves influencing the composition of the gut microbiota and the metabolic outputs produced by these bacteria, which in turn affect central nervous system function. The strain may also interact with immune pathways, potentially reducing systemic inflammation, which is often linked to conditions like depression and anxiety. At a molecular level, HN001 is thought to modulate neurotransmitter precursors and various immune signaling molecules. Its known ability for good gastrointestinal survival and colonization further enhances the bioavailability of its beneficial metabolites, allowing for sustained interaction with host systems.

Side effects

Lacticaseibacillus rhamnosus HN001 is considered safe, with no serious adverse events reported across numerous clinical trials involving hundreds of participants, including pregnant women. Occasional mild gastrointestinal symptoms, such as bloating or gas, may occur but are rare and generally transient. No significant drug interactions have been documented, and there are no known contraindications for its use. Studies specifically involving pregnant women have consistently shown excellent tolerability, reinforcing its safety profile for this sensitive population. As with any supplement, individuals with compromised immune systems or severe underlying health conditions should consult a healthcare professional before use, although no specific risks have been identified for HN001 in these groups.

Dosage

The effective dosage for Lacticaseibacillus rhamnosus HN001, as established in clinical trials, is typically around 6 × 10^9 CFU (colony-forming units) per day, administered orally. For mental health benefits in pregnant and postpartum women, supplementation usually commences between 14–16 weeks of gestation and continues through six months postpartum, especially if breastfeeding. This specific timing during pregnancy and postpartum appears crucial for achieving the observed mental health benefits. While there is no established maximum dose, the doses used in studies have been consistently well-tolerated. HN001 is available in various formulations, including capsules and fermented dairy products. To maintain probiotic viability, refrigeration is often recommended for products containing live cultures.

FAQs

Is HN001 safe during pregnancy?

Yes, randomized controlled trials have demonstrated both the safety and efficacy of HN001 for use in pregnant women, particularly for mental health benefits.

How long does it take for benefits to appear?

Improvements in mood and anxiety have been observed during pregnancy and were sustained through the postpartum period, suggesting benefits can emerge within weeks to months of consistent use.

Can it be used for general anxiety or depression?

While evidence is strongest for postpartum women, emerging research suggests potential benefits for stress reduction in other populations, though more studies are needed for general anxiety or depression.

Does it require refrigeration?

Typically, products containing live probiotic cultures like HN001 require refrigeration to maintain their viability and ensure the stated CFU count remains effective throughout their shelf life.

Is it effective alone or with other probiotics?

Most studies demonstrating the efficacy of HN001 have used it as a standalone supplement, indicating its independent effectiveness without the need for combination with other probiotic strains.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC5652021/ – This double-blind, randomized controlled trial involving 380 pregnant women found that L. rhamnosus HN001 supplementation from early pregnancy through 6 months postpartum significantly reduced postpartum depression and anxiety scores compared to placebo. The study was well-controlled and provided high-quality evidence for the mental health benefits of HN001 in this population.
https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0267778 – This RCT investigated the effects of HN001 on examination-related stress in university students. It reported reduced stress levels and improved psychological well-being, supporting broader mental health applications of HN001 beyond the postpartum period, though with a smaller sample size.
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2022.1031915/full – This systematic review and meta-analysis examined the role of probiotics in pregnancy, indicating a 33% reduction in gestational diabetes risk. While including various probiotic strains, some studies within this review featured HN001, suggesting its potential contribution to metabolic benefits during pregnancy, despite some heterogeneity.
https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/effect-of-probiotic-supplementation-in-pregnant-women-a-metaanalysis-of-randomised-controlled-trials/BC548A261958BFE35BB6FEF48CC41CD2 – This meta-analysis focused on probiotic supplementation in pregnant women, suggesting benefits for atopic eczema and neonatal outcomes. While strain-specific effects were less clear, it indicates potential additional health benefits of probiotics, including HN001, beyond mental health support in this population.